{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T17:10:34Z","timestamp":1732036234283},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.acuro.2016.07.006","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T08:08:53Z","timestamp":1472026133000},"page":"352-358","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["C\u00e1ncer vesical infiltrante: factores pron\u00f3sticos, seguimiento y tratamiento de las recidivas"],"prefix":"10.1016","volume":"41","author":[{"given":"C.","family":"Hern\u00e1ndez-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Herranz-Amo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moralejo-G\u00e1rate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Subir\u00e1-R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ca\u00f1o-Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Barbas-Bernardos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2016.07.006_bib0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","article-title":"The present an future burden of urinary bladder c\u00e1ncer in the world","volume":"27","author":"Ploeg","year":"2009","journal-title":"World J. Urol."},{"key":"10.1016\/j.acuro.2016.07.006_bib0175","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.acuro.2013.01.005","article-title":"Follow-up after radical cystectomy based on patterns of tumour recurrence and its risk factors","volume":"37","author":"Huguet","year":"2013","journal-title":"Actas Urol Esp."},{"key":"10.1016\/j.acuro.2016.07.006_bib0180","doi-asserted-by":"crossref","first-page":"e89259","DOI":"10.1371\/journal.pone.0089259","article-title":"Prognostic significance of lymphovascular invasion in radical cystectomy on patients with bladder cancer: a systematic review and meta-analysis","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.acuro.2016.07.006_bib0185","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejso.2016.02.011","article-title":"Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience","volume":"42","author":"Moschini","year":"2016","journal-title":"Eur J Surg Oncol."},{"key":"10.1016\/j.acuro.2016.07.006_bib0190","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.urology.2015.03.036","article-title":"The impact of tumour diameter and tumour necrosis on oncologic outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy","volume":"86","author":"Soave","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2016.07.006_bib0195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s12885-015-1448-x","article-title":"Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis","volume":"15","author":"Ku","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.acuro.2016.07.006_bib0200","first-page":"3967","article-title":"Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. International Bladder Cancer Nomogram Consortium","volume":"20","author":"Bochner","year":"2006","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.acuro.2016.07.006_bib0205","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.acuroe.2015.07.003","article-title":"External validacion of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes","volume":"39","author":"Ramirez-Backhaus","year":"2015","journal-title":"Actas Urol. Esp."},{"key":"10.1016\/j.acuro.2016.07.006_bib0210","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.eururo.2006.07.009","article-title":"Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series","volume":"51","author":"Bartsch GC1","year":"2007","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2016.07.006_bib0215","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.urology.2008.03.053","article-title":"Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy","volume":"72","author":"Canter","year":"2008","journal-title":"Urology."},{"key":"10.1016\/j.acuro.2016.07.006_bib0220","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00345-015-1693-2","article-title":"The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer","volume":"34","author":"Schubert","year":"2016","journal-title":"World J Urol."},{"key":"10.1016\/j.acuro.2016.07.006_bib0225","doi-asserted-by":"crossref","first-page":"e0130122","DOI":"10.1371\/journal.pone.0130122","article-title":"Perioperative blood transfusion promotes worse outcomes of bladder cancer after radical cystectomy: a systematic review and meta-analysis","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.acuro.2016.07.006_bib0230","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bju.12439","article-title":"Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder","volume":"113","author":"Kluth","year":"2014","journal-title":"BJU int"},{"key":"10.1016\/j.acuro.2016.07.006_bib0235","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/iju.12901","article-title":"Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy","volume":"22","author":"Oh","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.acuro.2016.07.006_bib0240","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.juro.2012.08.017","article-title":"Upper urinary tract recurrence following radical cystectomy for bladder c\u00e1ncer:13,185 patients","volume":"188","author":"Picozzi","year":"2012","journal-title":"J. Uro."},{"key":"10.1016\/j.acuro.2016.07.006_bib0245","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000329867","article-title":"The clinicopathologic correlates of celular atypia in urinary citology of ileal neobladders","volume":"5","author":"Cimino-Mathews","year":"2011","journal-title":"Acta Cytol."},{"key":"10.1016\/j.acuro.2016.07.006_bib0250","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2012.05.008","article-title":"Follow-up after surgical treatment of bladder c\u00e1ncer: a critical analysis of the literatura","volume":"62","author":"Soukup","year":"2012","journal-title":"Eur.Urol."},{"key":"10.1016\/j.acuro.2016.07.006_bib0255","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eururo.2010.05.041","article-title":"Do patients benefit from routine folow-up tedect recurrences after radical cystectomy and ileal orthotopic bladder substitution?","volume":"58","author":"Giannarini","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.acuro.2016.07.006_bib0260","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1002\/cncr.25202","article-title":"Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma","volume":"116","author":"Umbreit","year":"2010","journal-title":"Cancer."},{"key":"10.1016\/j.acuro.2016.07.006_bib0265","doi-asserted-by":"crossref","first-page":"236.e13","DOI":"10.1016\/j.urolonc.2015.11.025","article-title":"Oncologic surveillance in bladder cancer following radical cystectomy: A systematic review and meta-analysis","volume":"34","author":"Stewart-Merrill","year":"2016","journal-title":"Urologic Oncologic Seminars and Original Investigations."},{"key":"10.1016\/j.acuro.2016.07.006_bib0270","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1464-410X.2012.11133.x","article-title":"Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the canadian Bladder Cancer Network experience","volume":"110","author":"Yafi","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.acuro.2016.07.006_bib0275","doi-asserted-by":"crossref","first-page":"339.e1","DOI":"10.1016\/j.urolonc.2015.04.017","article-title":"Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based aprouch","volume":"33","author":"Stewart-Merrill","year":"2015","journal-title":"Urologic Oncology Seminars and Original Investigations."},{"key":"10.1016\/j.acuro.2016.07.006_bib0280","article-title":"Guidelines on muscle-invasive and metastatic bladder cancer","author":"Witjes","year":"2016","journal-title":"European Association of Urology"},{"key":"10.1016\/j.acuro.2016.07.006_bib0285","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1464-410X.2007.07335.x","article-title":"Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder","volume":"101","author":"Dhar","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2016.07.006_bib0290","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00345-012-0936-8","article-title":"Patterns of local recurrence after radical cystectomy in a contemporary series of patients with muscle-invasive bladder cancer","volume":"30","author":"Cornu","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.acuro.2016.07.006_bib0295","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000443336","article-title":"The role of surgery in local recurrences after radical cystectomy for bladder cancer","volume":"96","author":"Vilaseca","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.acuro.2016.07.006_bib0300","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/COC.0b013e31825d52f7","article-title":"Multimodality therapy including surgical resection and intraoperative electron radiotherapy for recurrent or advanced primary carcinoma of the urinary bladder o ureter","volume":"36","author":"Hallemeir","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.acuro.2016.07.006_bib0305","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0090-4295(00)00867-0","article-title":"Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial","volume":"57","author":"Otto","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2016.07.006_bib0310","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.eururo.2007.02.052","article-title":"Impact multimodal treatment on survival in patients with metastatic urothelial cancer","volume":"52","author":"Abe","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2016.07.006_bib0315","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.eururo.2008.11.039","article-title":"Surgery for metastatic urotelial carcinoma with curative intent: The german experience (AUO AB 30\/05)","volume":"55","author":"Lehman","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2016.07.006_bib0320","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.athoracsur.2011.03.097","article-title":"Is there a role a pulmonary metastasectomy with a curative intent in patients with metastatic urinary transitional cell carcinoma?","volume":"92","author":"Matsuguma","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.acuro.2016.07.006_bib0325","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.juro.2013.11.004","article-title":"Outcome of metastasectomy for urotelial carcinoma: A multi-institutional retrospective study in Japan","volume":"191","author":"Abe","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2016.07.006_bib0330","article-title":"EAU guidelines on urothelial carcinomas of the upper urinary tract","author":"Roupr\u00eat","year":"2016","journal-title":"European Association of Urology."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021048061630119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021048061630119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T21:56:17Z","timestamp":1536443777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021048061630119X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S021048061630119X"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2016.07.006","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C\u00e1ncer vesical infiltrante: factores pron\u00f3sticos, seguimiento y tratamiento de las recidivas","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2016.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}